Biogen Pharmachem Industries share news, announcements and annual reports
BIOGEN PHARMACHEM INDUSTRIES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹0.25₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.25.
30 Oct: open ₹0.25, high ₹0.25, low ₹0.24
52-week range of traded prices to 30 Oct 2026
₹0.23Low, 23 Oct 2026₹0.72High, 4 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 23,53,079
Biogen Pharmachem Industries board meetings
131 filed, newest first. Page 1 of 3.
Oct 2026
23 Oct · Board meeting
Meeting on 3 Nov 2026: quarterly results
Jul 2026
21 Jul · Board meeting
Meeting on 5 Aug 2026: quarterly results
May 2026
4 May · Board meeting
Meeting on 14 May 2026: audited results
Mar 2026
Feb 2026
24 Feb · Board meeting
Meeting on 23 Mar 2026: bonus issue3 Feb · Board meeting
Meeting on 11 Feb 2026: quarterly results
Jan 2026
Oct 2025
30 Oct · Board meeting
Meeting on 7 Nov 2025: quarterly results
Jul 2025
16 Jul · Board meeting
Meeting on 23 Jul 2025: quarterly results
May 2025
12 May · Board meeting
Meeting on 23 May 2025: audited results
Apr 2025
15 Apr · Board meeting
Meeting on 15 Apr 2025: preferential issue of shares8 Apr · Board meeting
Meeting on 8 Apr 20258 Apr · Board meeting
Mar 2025
11 Mar · Board meeting
Meeting on 11 Mar 20257 Mar · Board meeting
Meeting on 7 Mar 2025
Jan 2025
22 Jan · Board meeting
Meeting on 5 Feb 2025: quarterly results
Nov 2024
29 Nov · Board meeting
Meeting on 29 Nov 2024
Oct 2024
15 Oct · Board meeting
Meeting on 13 Nov 2024: quarterly results
Aug 2024
1 Aug · Board meeting
Meeting on 13 Aug 2024: preferential issue of shares
Jul 2024
25 Jul · Board meeting
Meeting on 1 Aug 2024: quarterly results
May 2024
25 May · Board meeting
16 May · Board meeting
Meeting on 25 May 2024: audited results
Jan 2024
16 Jan · Board meeting
Meeting on 22 Jan 2024: quarterly results